Allspring Global Investments
NEXI

Allspring Global Investments’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Allspring Global Investments’s Portfolio NEXI Stock Details NEXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-153
Closed -$16K – 2992
2022
Q1 		$16K Buy
+153
New +$11.2K ﹤0.01% 2953

Other funds holding NEXI

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AO
Allen Operations New York $670M AUM 26.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
KHCM
Kettle Hill Capital Management New York $399M AUM 10.05% 1-Year Est. Return

Allspring Global Investments's NEXI Position: Q2 2022 in Review

Allspring Global Investments sold out of NexImmune, Inc. Common Stock (NEXI) in Q2 2022, closing a stake of 153 shares — an estimated $16K sold.

Allspring Global Investments first reported a position in NEXI in Q1 2022 and held it in 1 quarter. The position peaked at $16K in Q1 2022. 44 funds tracked by Wall St. Rank hold NEXI as of Q2 2022.

  • Allspring Global Investments reported no remaining NexImmune, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Allspring Global Investments sold 153 NexImmune, Inc. Common Stock shares in Q2 2022, an estimated $16K.
  • Allspring Global Investments first reported a position in NexImmune, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Allspring Global Investments's NexImmune, Inc. Common Stock position peaked at $16K in Q1 2022.
  • 44 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q2 2022.

Based on Allspring Global Investments's 13F filing for Q2 2022, filed 25 Jul 2022.